Announcing a new article publication for BIO Integration journal. Nitrofurantoin is a BCS II drug with a low solubility and dissolution rate. Therefore, the pharmaceutical applications of ...
Paul Smaltz, Senior Vice President of BASF Pharma Solutions, explains how the company acts as a strategic partner to the ...
Boehringer Ingelheim has struck a deal to apply Nanoform's nanoparticle technology to its preclinical pipeline prospects. The master services agreement positions the partners to work to improve the ...
RespireRx Pharmaceuticals Inc. RSPI in association with Jeffrey King managing attorney at Patent Networks Law Group, has filed a provisional patent application describing novel lipid-based formulation ...
Cyclodextrins, a fascinating class of cyclic oligosaccharides, have garnered significant attention due to their unique ...
These plots show powder X-ray diffraction measurements of three different types of formulations: simple mixing (a, d), the conventional evaporation/condensation ...
QUAKERTOWN, Pa.--(BUSINESS WIRE)--Microsize today announced the strategic investment and partnership with Helsinki-based The Solubility Company. Microsize's investment accelerates plans for The ...
Devin Miles, ND Abstract This article reviews the clinical evidence supporting curcumin’s role in inflammation, joint health, ...
Scientists increased the bioavailability of CBD in in-vitro models. The findings were published in the International Journal of Molecular Sciences and may have significant implications for the future ...
Breast cancer (BCA) is one of the most common cancers worldwide, with high mortality and morbidity in women. This review focuses on the applications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results